135 related articles for article (PubMed ID: 37306943)
1. Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study.
Lu K; Chiu KY
Clin Transplant; 2023 Oct; 37(10):e15047. PubMed ID: 37306943
[TBL] [Abstract][Full Text] [Related]
2. Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center.
Tsaur I; Karalis A; Probst M; Blaheta RA; Scheuermann EH; Gossmann J; Kachel HG; Hauser IA; Jonas D; Obermüller N
Cancer Sci; 2010 Nov; 101(11):2430-5. PubMed ID: 20707803
[TBL] [Abstract][Full Text] [Related]
3. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
4. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
5. De Novo Urologic Malignancies in Renal Transplant Recipients.
Antunes H; Tavares-da-Silva E; Oliveira R; Carvalho J; Parada B; Bastos C; Figueiredo A
Transplant Proc; 2018 Jun; 50(5):1348-1354. PubMed ID: 29753463
[TBL] [Abstract][Full Text] [Related]
6. Urological tumors in renal transplantation.
Tillou X; Doerfler A
Minerva Urol Nefrol; 2014 Mar; 66(1):57-67. PubMed ID: 24721941
[TBL] [Abstract][Full Text] [Related]
7. Management of Urological Malignancy in Heart and Lung Transplant Recipients: An Irish National Cohort Study.
Keenan RA; Haroon U; Ryan P; Harrington B; Jones A; Aboelmagd M; Connolly S; O'Mally KJ; Galvin D; Hegarty N
Exp Clin Transplant; 2021 Oct; 19(10):1069-1075. PubMed ID: 34641776
[TBL] [Abstract][Full Text] [Related]
8. Malignancy following renal transplantation.
Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
[TBL] [Abstract][Full Text] [Related]
10. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
[TBL] [Abstract][Full Text] [Related]
11. De-novo malignancies after kidney transplantation: A long-term observational study.
Fröhlich FA; Halleck F; Lehner L; Schrezenmeier EV; Naik M; Schmidt D; Khadzhynov D; Kast K; Budde K; Staeck O
PLoS One; 2020; 15(11):e0242805. PubMed ID: 33253202
[TBL] [Abstract][Full Text] [Related]
12. Malignancy after renal transplantation: a single-center experience.
Vrotniakaite K; Jaceviciute R; Rudminiene I; Laucyte-Cibulskiene A; Rainiene T; Jankevicius F; Zelvys A; Miglinas M
Ann Transplant; 2014 Sep; 19():456-63. PubMed ID: 25223375
[TBL] [Abstract][Full Text] [Related]
13. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
14. De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study.
Tsai HI; Lee CW; Kuo CF; See LC; Liu FC; Chiou MJ; Yu HP
Oncotarget; 2017 May; 8(22):36685-36695. PubMed ID: 27821818
[TBL] [Abstract][Full Text] [Related]
15. De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years.
Zavos G; Moris D; Kostakis ID; Vernadakis S; Bokos J; Zavvos V; Lionaki S; Boletis J
Exp Clin Transplant; 2015 Aug; 13(4):313-8. PubMed ID: 26295181
[TBL] [Abstract][Full Text] [Related]
16. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
[TBL] [Abstract][Full Text] [Related]
17. Malignancies in adult kidney transplant candidates and recipients: current status.
Serkies K; Dębska-Ślizień A; Kowalczyk A; Lizakowski S; Małyszko J
Nephrol Dial Transplant; 2023 Jun; 38(7):1591-1602. PubMed ID: 35998321
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignancy in kidney transplant recipients: a nationwide population-based cohort study.
Jung SW; Lee H; Cha JM
BMC Nephrol; 2022 Apr; 23(1):160. PubMed ID: 35484531
[TBL] [Abstract][Full Text] [Related]
19. Risk of Genitourinary Malignancy in the Renal Transplant Patient.
Jiang S; Regmi S; Jackson S; Calvert C; Jarosek S; Pruett T; Warlick C
Urology; 2020 Nov; 145():152-158. PubMed ID: 32763322
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and Outcomes of De Novo Genitourinary Malignancy in Solid Organ Transplant Recipients at the University of Minnesota.
Cleveland B; Gardeck A; Holten M; Jiang S; Jackson S; Pruett T; Warlick C
Transplant Proc; 2023 Nov; 55(9):2027-2034. PubMed ID: 37775402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
